Is Lantheus Holdings Inc (LNTH) overvalued? · P/E 23, rev $1.53B
Lantheus Holdings Inc (LNTH) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether Lantheus Holdings Inc (LNTH) looks expensive on cached numbers — not a short thesis.
Latest reported LNTH revenue for 2024-12-31 was $1.53B. Net income was $312.4M. Revenue was up 18.3% from 2023-12-31 to 2024-12-31. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.
LNTH currently screens at market cap $5.56B and trailing P/E 22.9. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LNTH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LNTH stock page for the full model, not this heading.
Not investment advice.